INSP — Inspire Medical Systems Cashflow Statement
0.000.00%
Last trade - 00:00- $1.44bn
- $1.14bn
- $911.98m
Annual cashflow statement for Inspire Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -42 | -44.9 | -21.2 | 53.5 | 145 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 27.6 | 52.8 | 83.7 | 108 | 134 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.86 | 1.81 | -40.8 | -37.7 | -87.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -20.1 | 11.6 | 24.7 | 130 | 117 |
| Capital Expenditures | -4.67 | -9.1 | -23.6 | -39.1 | -38.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 33.8 | -10.5 | -271 | -74 | 59.9 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 29.1 | -19.6 | -295 | -113 | 21.4 |
| Financing Cash Flow Items | 0 | -0.043 | -17.2 | -5.17 | -23 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.9 | 235 | 13.9 | -52.4 | -183 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.9 | 227 | -256 | -35.4 | -45.3 |